+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
544440 CRYOGENIC

Cryogenic OGS Share Price

 

 

Cryogenic OGS live price: ₹277.95. It opened at ₹278 vs previous close ₹272; intraday high/low: ₹279/₹270. The 50 & 200 DMA stand at ₹219.19/₹182.44.

Cryogenic OGS Performance

  • Today's Low
  • ₹270
  • Today's High
  • ₹279
  • 52 Week Low
  • ₹89
  • 52 Week High
  • ₹288
  • Open Price₹278
  • Previous Close₹272
  • Volume13,500
  • 50 DMA₹219.19
  • 100 DMA₹199.59
  • 200 DMA₹182.44

Cryogenic OGS Chart

Investment Returns

  • Over 1 Month + 36.18%
  • Over 3 Month + 62.88%
  • Over 6 Month + 59.74%

Smart Investing Starts Here Start SIP with Cryogenic OGS for Steady Growth!

Invest Now

Cryogenic OGS Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 39
  • PEG Ratio
  • -
  • Market Cap Cr
  • 397
  • P/B Ratio
  • 7.3
  • Average True Range
  • 12.56
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 16.49
  • RSI
  • 67.48
  • MFI
  • 81.04

Latest Stock News Updates

Cryogenic OGS shares post bumper debut, list at 90% premium on BSE SME

Cryogenic OGS shares listed at 89.30 per share, representing a premium of 42 per share or a 90 per cent gain over the issue price of 47

Cryogenic OGS Financials

Cryogenic OGS Technicals

EMA & SMA

Current Price
₹277.95
+ 5.95 (2.19%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹245.50
  • 50 Day
  • ₹219.20
  • 100 Day
  • ₹199.60
  • 200 Day
  • ₹182.40

Resistance and Support

274.32 Pivot Speed
  • R3 287.58
  • R2 283.27
  • R1 278.63
  • S1 269.68
  • S2 265.37
  • S3 260.73

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Cryogenic OGS Limited manufactures fluid control equipment for oil, gas, petrochemicals, chemicals, and liquor industries. With over 90% repeat business, it offers metering, filtration, pressure reduction, dosing, and blending systems, complying with global standards like API, ASME, and ATEX.

Cryogenic Ogs Ltd has an operating revenue of Rs. 87.14 Cr. on a trailing 12-month basis. An annual revenue growth of 26% is outstanding, Pre-tax margin of 33% is great, ROE of 18% is exceptional. The company has a reasonable debt to equity of 15%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 25% and 42% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 18% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 94 which is a GREAT score indicating consistency in earnings, a RS Rating of 96 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 163 indicates it belongs to a poor industry group of Consumer Prod-Specialty and a Master Score of B is close to being the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Cryogenic OGS Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-04-30 Audited Results
2025-10-16 Half Yearly Results

Cryogenic OGS Shareholding Pattern

74.29%
20.42%
5.29%

Cryogenic OGS FAQs

Cryogenic OGS share price is ₹277 As on 19 June, 2026 | 18:05

The Market Cap of Cryogenic OGS is ₹396.9 Cr As on 19 June, 2026 | 18:05

The P/E ratio of Cryogenic OGS is 39 As on 19 June, 2026 | 18:05

The PB ratio of Cryogenic OGS is 7.3 As on 19 June, 2026 | 18:05

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23